Rss Feed

New research explains how low levels of the electrolyte sodium in the blood can disrupt the timing of the heartbeat in patients taking widely used rhythm-control medications such as flecainide, which is commonly prescribed for atrial fibrillation and other fast or irregular heart rhythms.

Immune checkpoints are regulatory proteins that prevent the immune system from attacking healthy tissues.

A cancer diagnosis is a life-changing event for patients that can cause short- and long-term mental health concerns as they shift to living within a new timeline driven by weeks or months between medical follow-up appointments.

Although the respiratory system is one of the main entry points for microplastics and nanoplastics (MNPs) from the air into the body, little is known about the effects of these tiny particles on the lungs.

Elegen, a global leader in next-generation DNA manufacturing, and Nutcracker Therapeutics, a global leader in next-generation RNA design and manufacturing, today announced the launch of a pilot program to demonstrate the industry's first fully synthetic, cell-free manufacturing platform for RNA-based personalized cancer therapeutics (PCTs).

FEMI, an AI model for IVF, uses 18 million images to improve embryo assessment, offering a non-invasive, cost-effective solution for better success rates.

Scientists from the Centenary Institute and the University of Sydney have made a landmark discovery that could lead to safer and more effective gene therapies for a range of serious genetic disorders including Duchenne muscular dystrophy, Pompe disease and hemophilia.

A team of researchers at ChristianaCare's Helen F. Graham Cancer Center & Research Institute and the University of Delaware believe they've found an answer.

In a comprehensive Genomic Press perspective (peer-reviewed review) article, an international team of neuroscientists has outlined crucial validity standards that could transform how researchers use stem cell technology to study devastating brain disorders.

Stroke is said to be the second leading cause of death worldwide after heart disease. To prevent the death of neurons in the brain, a research group led by Osaka Metropolitan University Associate Professor Hidemitsu Nakajima of the Graduate School of Veterinary Science has developed a drug that inhibits a protein involved in cell death.

A study presented today at the Society of NeuroInterventional Surgery's (SNIS) 22nd Annual Meeting found that almost half of gunshot wound injuries to the brain in children and young adults include penetrating cerebrovascular injuries (PCVIs).

Because unpleasant withdrawal symptoms fuel nicotine addiction's high relapse rate, targeting their underlying mechanisms with treatments may promote continued abstinence from the drug.

Progress towards universal access to safe, affordable surgical care is dangerously off track as at least 160 million patients each year are unable to receive surgery - with Low- and Middle-income Countries (LMICs) bearing the brunt of the crisis, a new study reveals.

People with Parkinson's disease (PD) have an odor that can be reliably detected from skin swabs by trained dogs, a new study has shown.

Lower levels of certain vitamins and minerals were found to be associated with chronic pain in a recently completed study led by researchers at the University of Arizona Health Sciences and published in Pain Practice.

Popular anti-obesity medications continue to be effective for weight loss even when availability and access is interrupted, according to a study being presented by a private weight-loss company Monday at ENDO 2025, the Endocrine Society's annual meeting in San Francisco, Calif.

MiROM identifies proteins by using mid-infrared light to detect molecular vibrations – essentially the natural "dance" of molecules within protein structures. Unlike optical spectroscopy, which measures light attenuation, optoacoustics capture ultrasound waves generated when proteins absorb infrared light.

Insomnia could explain why adults with ADHD traits report having a lower quality of life, according to new research led by the University of Southampton and the Netherlands Institute of Neuroscience.

People with the rare growth hormone disorder acromegaly have a significantly higher risk of developing various types of cancer, often at ages younger than typically seen in the general population, according to a study being presented Monday at ENDO 2025, the Endocrine Society's annual meeting in San Francisco, Calif.

A nationwide cohort study of Danish children examined the association between cumulative aluminum exposure from early childhood vaccination and the risk for development of autoimmune, atopic or allergic, and neurodevelopmental disorders.